Representatives Jackson and Pugliese, prime bill sponsors, presented House Bill 25-1293 regarding drug overdose education and opioid antagonists in schools. Amendment L.001 (Attachment A) and L.002 (Attachment B) were distributed. The bill sponsors answered questions from members of the committee.

John Armstrong, Legislative Council Staff, answered questions from members of the committee.

Ms. Breeah Kinsella, representing Colorado Providers Association, testified in opposition to the bill. Ms. Betsy Craft, representing the Colorado Drug Policy Coalition, testified in opposition to the bill. Dr. Melissa Mouton, representing themself, testified in opposition to the bill. Ms. Jennifer Dillon, representing the Colorado Drug Policy Coalition, testified in opposition to the bill.

Members of the panel answered questions from members of the committee.

Ms. Lisa Ward, representing the Colorado Providers Association, read testimony for Racquel Garcia opposition to the bill. Lisa Raville, representing the Harm Reduction Action Center, testified in opposition to the bill.

Members of the panel answered questions from members of the committee.

Jacob Rehring, representing themself, testified in support of the bill. Wendy Buxton-Andrade, representing Mental Health Colorado, testified in support of the bill. Dr. Donald Stader, representing The Naloxone Project, testified in support of the bill. Dr. Priscilla Rahn, representing themself, testified in support of the bill. Evie Hudak, representing Colorado PTA, testified in support of the bill.

Written testimony was submitted to the committee (Attachment C).

The bill sponsors distributed and explained amendment L.003 (Attachment D).

The bill sponsors provided closing remarks on House Bill 25-1293. Members of the committee provided closing remarks.